SG/CALL/FRESENIUS/23/0.1/20.09.24 Share Price

Warrant

DE000SV1ZAQ3

Delayed Deutsche Boerse AG 12:18:45 04/07/2024 BST
0.58 EUR +3.57% Intraday chart for SG/CALL/FRESENIUS/23/0.1/20.09.24
Current month+9.80%
1 month-13.85%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
04/07/24 0.58 +3.57%
03/07/24 0.56 0.00%
02/07/24 0.56 0.00%
01/07/24 0.56 +9.80%
28/06/24 0.51 -3.77%

Delayed Quote Deutsche Boerse AG

Last update July 04, 2024 at 12:18 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SV1ZAQ
ISINDE000SV1ZAQ3
Date issued 10/03/2023
Strike 23
Maturity 20/09/2024 (78 Days)
Parity 10 : 1
Emission price 0.44
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.93
Lowest since issue 0.3
Delta0.95x
Omega 4.634
Premium0.94x
Gearing4.89x
Moneyness 1.243
Difference Strike -5.665
Difference Strike %-24.63%
Spread 0.01
Spread %1.69%
Intrinsic value 0.5590

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.46 EUR
Average target price
37.26 EUR
Spread / Average Target
+30.91%
Consensus